It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
I'm going to say no. Bad information. You would have to be very specific in how they are going to overtake the USA, or in which way they are going to.
Originally posted by boncho
I'm going to say no. Bad information. You would have to be very specific in how they are going to overtake the USA, or in which way they are going to.
Originally posted by Nightstalker44
In my opinion, there army already scares me...and now they have science....
Originally posted by lnr42
reply to post by boncho
The thread title isnt 'China to invade US in two years'. Why are potential allies etc relevant?
I'm pretty sure the (English!) Think Tank that put this report together have considered all relevant variables before publishing.
Along with the growth of the Chinese economy, this is yet another indicator of China's extraordinarily rapid rise as a global force.
"I think this is positive, of great benefit, though some might see it as a threat and it does serve as a wake-up call for us not to become complacent."
The changes reflect an emerging new world order in science, emphasising collaboration between nations which have different areas of expertise.
Brazil, India and several countries in Asia, the Middle East and North Africa
Iran has said it is committed to a "comprehensive plan for science" which will see research and development investment increased from less than 1% to 4% of its gross domestic product by 2030.
It will examine how international networks of collaboration are changing the way in which scientific research is conducted and funded, and the implications of these developments for global decision makers in science, business, NGOs and government.
Finally, the report considered the role of international scientific collaboration in addressing some of the most pressing global challenges of our time, concentrating on the IPCC, CGIAR, the Gates Foundation, ITER and efforts to deploy carbon capture and storage technology
Professor Llewellyn Smith commented: “Global issues, such as climate change, potential pandemics, bio-diversity, and food, water and energy security, need global approaches . These challenges are interdependent and interrelated, with complicated dynamics that are often overlooked by policies and programmes put in place to address them. Science has a crucial role in identifying and analysing these challenges, and must be considered in parallel with social, economic and political perspectives to find solutions.”
Originally posted by lnr42
reply to post by Wookiep
What makes you think Chinas arent as well?
They have a huge military budget and are even less restricted than the American forces (are supposed to be...).
ETA: Yea the avatars freaky aint it? loledit on 28-3-2011 by lnr42 because: (no reason given)
chinas economic rise is to the simple fact they dont have liberals.
But today multinationals are beginning to leverage the skills of Indian and Chinese knowledge workers to innovate, and they are building strong R&D capabilities in these markets.
Innovation in China and India, however, has not grown on a truly global, commercially significant scale. Indian companies have yet to come up with significant innovations in entire product lines. Chinese outfits have launched clever but imitative products, and China's R&D capabilities lag those of Taiwan and South Korea.
China and India rank 49th and 50th in the world respectively in terms of productivity growth. Their economies face major challenges to improved innovation. They lack end-to-end logistics, effective infrastructure, and strong regulatory systems. By understanding such weaknesses, corporations can devise alternate strategies and business models to transform the two countries into growth markets.
About China Watch
The gap between the Chinese and global pharmaceutical sectors has widened in recent years, according to a new report by the National Research Center for Science and Technology for Development. The study, titled Can China’s Biopharmaceutical Industry Catch Up with Industrialized Countries?, attributes the Chinese lag to incomplete government incentives, a lack of collaboration between domestic research institutes and drug companies, and the absence of effective intellectual property rights.
The report points out that while government subsidies to fuel pharmaceutical development in China have remained strong, the country has not yet created tax incentives or an incentive environment for approving new drugs and managing drug pricing, all of which provide a platform for local pharmaceutical companies to nurture high technologies. Moreover, China’s pharmaceutical industry still lacks independent and efficient research and development capabilities, with poor corporate support for new drug research. The sector is also challenged by a lack of intellectual property rights to effectively protect domestic innovation, contributing to destructive competition in the field.